User profiles for K. Noda

Koji Noda

- Verified email at icrr.u-tokyo.ac.jp - Cited by 9807

Kuniaki Noda

- Verified email at akane.waseda.jp - Cited by 2277

The α1-6-fucosyltransferase gene and its biological significance

E Miyoshi, K Noda, Y Yamaguchi, S Inoue… - … et Biophysica Acta (BBA …, 1999 - Elsevier
… Author links open overlay panel Eiji Miyoshi , Katsuhisa Noda , Yukihiro Yamaguchi , Shinya
… Although the K m values of each α1-6FucT differ, there is no direct evidence that these α1-…

[HTML][HTML] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

K Noda, Y Nishiwaki, M Kawahara… - … England Journal of …, 2002 - Mass Medical Soc
Background Irinotecan hydrochloride, a topoisomerase I inhibitor, is effective against small-cell
lung cancer. In a phase 2 study of irinotecan plus cisplatin in patients with extensive small…

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small-cell lung cancer

…, D Rischin, R Eek, T Horai, K Noda… - Journal of clinical …, 2023 - ingentaconnect.com
PURPOSE To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839];
AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase …

[HTML][HTML] Leukocyte adhesion molecules in diabetic retinopathy

K Noda, S Nakao, S Ishida, T Ishibashi - Journal of ophthalmology, 2012 - hindawi.com
… Correspondence should be addressed to Kousuke Noda, nodako@med.hokudai.ac.jp …
Copyright © 2012 Kousuke Noda et al. This is an open access article distributed under the …

Metabolic gene polymorphism frequencies in control populations

…, CM Maugard, S Morita, V Nazar-Stewart, K Noda… - … Biomarkers & Prevention, 2001 - AACR
Using the International Project on Genetic Susceptibility to Environmental Carcinogens (GSEC)
database containing information on over 15,000 control (noncancer) subjects, the allele …

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

…, T Sugiyama, S Kodama, E Kimura, K Ochiai, K Noda - The Lancet, 2009 - thelancet.com
Background Paclitaxel and carboplatin given every 3 weeks is standard treatment for advanced
ovarian carcinoma. Attempts to improve patient survival by including other drugs have …

The major upgrade of the MAGIC telescopes, Part II: A performance study using observations of the Crab Nebula

…, A Niedzwiecki, K Nilsson, K Nishijima, K Noda… - Astroparticle …, 2016 - Elsevier
MAGIC is a system of two Imaging Atmospheric Cherenkov Telescopes located in the
Canary island of La Palma, Spain. During summer 2011 and 2012 it underwent a series of …

Catalytic asymmetric epoxidation of unfunctionalized olefins

R Irie, K Noda, Y Ito, N Matsumoto, T Katsuki - Tetrahedron letters, 1990 - Elsevier
Manganese complex of the optically active salen ligand [N,N'-bis[(S)-3-(1-phenylpropyl)salicylidene]-(1R,2R)-1,2-diphenylethylenediaminato]
was found to be an effective catalyst for …

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the …

…, S Yokota, Y Nishiwaki, K Watanabe, K Noda… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the optimal timing for thoracic radiotherapy (TRT) in limited-stage
small-cell lung cancer (LS-SCLC), the Lung Cancer Study Group of the Japan Clinical …

[HTML][HTML] Audio-visual speech recognition using deep learning

K Noda, Y Yamaguchi, K Nakadai, HG Okuno… - Applied intelligence, 2015 - Springer
Audio-visual speech recognition (AVSR) system is thought to be one of the most promising
solutions for reliable speech recognition, particularly when the audio is corrupted by noise. …